Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Mirabegron vs. Oxybutynin for Overactive Bladder

Mechanism of Action and Efficacy

  • Oxybutynin is an antimuscarinic agent that blocks acetylcholine receptors, reducing involuntary detrusor contractions, as noted by The Journal of Urology 2, 3

Side Effect Profile

  • Oxybutynin has higher rates of dry mouth, constipation, and blurred vision, according to The Journal of Urology 2, 3
  • Oxybutynin has an increased risk of cognitive impairment, especially in elderly patients, as reported by European Urology 4

Special Populations

  • Oxybutynin should be used with extreme caution in elderly patients due to increased risk of anticholinergic side effects and higher potential for cognitive impairment, as stated by The Journal of Urology 2, 3

Treatment Algorithm

  • First-line therapy includes behavioral therapies, such as bladder training, pelvic floor exercises, and fluid management, as recommended by The Journal of Urology 2, 3
  • For inadequate response to monotherapy, consider combination therapy with mirabegron plus an antimuscarinic, according to The Journal of Urology 1, 5

Common Pitfalls and Caveats

  • Avoid oxybutynin in patients with narrow-angle glaucoma, history of urinary retention, impaired gastric emptying, as cautioned by The Journal of Urology 2, 3